1. Home
  2. NUVL

as 10-07-2025 3:29pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Founded: 2017 Country:
United States
United States
Employees: 200 City: CAMBRIDGE
Market Cap: 6.0B IPO Year: 2021
Target Price: $118.89 AVG Volume (30 days): 396.7K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -4.90 EPS Growth: N/A
52 Week Low/High: $55.53 - $106.32 Next Earning Date: 11-11-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Stock Insider Trading Activity of Nuvalent Inc. (NUVL)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Balcom Alexandra NUVL Chief Financial Officer Sep 30 '25 Sell $85.06 20,000 $1,701,200.00 61,734
Noci Darlene NUVL Chief Development Officer Sep 29 '25 Sell $83.27 4,000 $332,288.05 48,034
Balcom Alexandra NUVL Chief Financial Officer Sep 29 '25 Sell $85.01 7,588 $645,055.88 61,734
Porter James Richard NUVL President and CEO Sep 15 '25 Sell $79.28 27,000 $2,135,055.30 251,159
Pelish Henry E. NUVL Chief Scientific Officer Sep 10 '25 Sell $78.83 3,725 $293,641.75 65,963
Noci Darlene NUVL Chief Development Officer Aug 25 '25 Sell $74.84 4,000 $298,488.74 48,034
Porter James Richard NUVL President and CEO Aug 15 '25 Sell $76.03 27,000 $2,036,325.40 251,159

Share on Social Networks: